Skip to main content
. 2020 Apr 27;12(3):235–245. doi: 10.1136/flgastro-2019-101391

Table 10.

Haematological and biochemical blood test monitoring schedule following vertical sleeve gastrectomy, roux-en-Y gastric bypass and bilopancreatic diversion with duodenal switch23 24.

Blood test Vertical sleeve gastrectomy Roux-en-Y gastric bypass
Bilopancreatic diversion with duodenal switch
Full blood count At 3,6 and 12 months in the first year, annually thereafter At 3,6 and 12 months in the first year, annually thereafter
Urea and electrolytes At 3,6 and 12 months in the first year, annually thereafter At 3,6 and 12 months in the first year, annually thereafter
Liver function At 3,6 and 12 months in the first year, annually thereafter At 3,6 and 12 months in the first year, annually thereafter
Iron studies, Folate, Ca2+, Vit D, PTH At 3,6 and 12 months in the first year, annually thereafter At 3,6 and 12 months in the first year, annually thereafter
Vitamin B12 6 monthly first year, annually thereafter. Consider sooner if anaemia or peripheral neuropathy
No need to monitor if receiving intramuscular B12 injections
6 and 12 months in first year, annually thereafter. Consider sooner if anaemia or peripheral neuropathy
No need to monitor if receiving intramuscular B12 injections
Zinc, copper Not routinely Annually. Consider sooner if unexplained anaemia, hair loss, change in taste acuity, poor wound healing
Selenium Not routinely Not routinely. Consider if unexplained fatigue, anaemia, metabolic bone disease, diarrhoea, heart failure
Vitamin A Not routinely Annually for BPD-DS. Consider in RYGB if steatorrhoea or night blindness
Vitamin E, K Not routinely Not routinely. Consider if unexplained anaemia, peripheral neuropathy, coagulopathy

BPD-DS, bilopancreatic diversion with duodenal switch; Ca2+, calcium; PTH, parathyroid hormone; RYGB, roux-en-Y gastric bypass; Vit D, vitamin D.